Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
75 hedge funds and large institutions have $234M invested in Myovant Sciences Ltd. in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 14 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
3% less funds holding
Funds holding: 77 → 75 (-2)
54% less capital invested
Capital invested by funds: $515M → $234M (-$280M)
79% less call options, than puts
Call options by funds: $490K | Put options by funds: $2.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.36M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$6.73M |
| 3 |
Morgan Stanley
New York
|
+$5.2M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.05M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$37.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.76M |
| 3 |
Millennium Management
New York
|
-$5.61M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.62M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.58M |
MYOV Hedge Fund Activity: Q1 2020 in Review
75 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2020, worth a combined $234M — down 54% from $515M a quarter earlier.
Fund positioning in MYOV was balanced in Q1 2020: 14 funds opened new positions, 14 closed out, 27 added to existing stakes and 23 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $7.36M. The largest seller was Eventide Asset Management, cutting an estimated $37.3M.
- 75 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2020, down from 77 in Q4 2019.
- Funds reported $234M of Myovant Sciences Ltd. stock for Q1 2020, down 54% quarter-over-quarter.
- 14 funds opened new Myovant Sciences Ltd. positions in Q1 2020 and 14 closed out, a net change of 0 holders.
- The largest Myovant Sciences Ltd. buyer in Q1 2020 was Opaleye Management, an estimated $7.36M added.
- The largest Myovant Sciences Ltd. seller in Q1 2020 was Eventide Asset Management, an estimated $37.3M sold.
Based on aggregated 13F filings for Q1 2020.